CCA News
CCA attends Coalition of Preventative Health meeting at CHF
CCA recently attended the Consumer Health Forum (CHF) in Sydney, meeting as part of the Coalition of Preventative Health. Image:…
Kid’s Fun Day – Channel 7 and 9 news reports
We held our Kids Fun Day in Brisbane on Sunday, November 9th at Urban Xtreme. Parents had the opportunity to meet…
New Medicare Benefits Schedule (MBS) item for faecal calprotectin testing
From 1 November 2025 patients diagnosed with IBD who are symptomatic will be able to access a Medicare benefit for…
CCA receives Health Industry Hub Catalyst for Change 2025 award!
Together with the Australian Patient Advocacy Alliance, CCA are really pleased to announce that we were the recipient of the Unmasking Election 2025 award at the Health Industry Hub Catalysts for Change Awards 2025!
Live Fearless Walk in Melbourne!
Thanks so much to everyone who came along for the Live Fearless Walk in Melbourne on Sunday morning! It was so fantastic seeing such a strong presence as everyone raised awareness for Inflammatory Bowel Disease!
CCA CEO attends APAC summit
CCA CEO Leanne Raven was recently in Fukuoka, Japan, for the launch of the Statement of Consensus: Removing Barriers for Inflammatory Bowel Disease Patients in the Asia-Pacific Region.
“I Thought My Stoma Bag Would Ruin My Life” – ABC Science documentary
Thank you so much to ABC Science and to Abbey for sharing your story! We encourage you to watch the documentary here.
Watch a recording of the IBD in the workplace webinar
Watch a recording of the IBD in the workplace webinar
CCA IBD PhD scholarship 2025 – applications now open
The Crohn’s & Colitis Australia IBD PhD Scholarship makes a provision of $32,000 per annum for up to (3) years full-time supporting CCA’s strategic priority of building inflammatory bowel disease (IBD) research capacity in Australia.
Upcoming webinar – ageing with IBD: finances and aged care
Join us on Thursday 18th September for the first webinar in our Ageing with IBD series
Free IBD in the workplace online webinar
To celebrate the launch of GutSmart's IBD in the Workplace resource, CCA invites you to an online webinar on Wednesday, 20 August, at 7pm AEST, which focuses on working with IBD.
PBS adds Ustekinumab and Omalizumab biosimilars.
From August 1, 2025, biosimilars SteQeyma (ustekinumab) has been listed on the Pharmaceutical Benefits Scheme (PBS) for some Crohn’s disease…